Department of Internal Medicine and Biochemistry, University of New Mexico, School of Medicine, MSC 10 5550, Albuquerque, NM, 87131, USA.
University of Pennsylvania, Philadelphia, PA, USA.
BMC Nephrol. 2020 Jul 22;21(1):291. doi: 10.1186/s12882-020-01954-y.
Chronic kidney disease (CKD) is an increasing epidemic globally that is associated with adverse health outcomes including end stage kidney disease (ESKD), cardiovascular disease (CVD), and death. American Indians (AIs) have a higher prevalence of CKD than most other racial/ethnic groups, due in part to a high prevalence of type 2 diabetes. Other genetic and environmental factors not yet identified may also contribute to the disproportionate burden of CKD in AIs.
We will establish 3 clinical centers to recruit AIs from the Southwest United States (US) to expand the Chronic Renal Insufficiency Cohort (CRIC) study. We will follow the current CRIC protocol for kidney and cardiovascular measures and outcomes, which include ambulatory monitoring of kidney function and the use of mobile health technologies for CVD sub-phenotyping, and compare the outcomes in AIs with those in other racial/ethnic groups in CRIC.
AI-CRIC will identify the role of various risk factors for rapid loss of kidney function among AIs of the Southwest US. In addition, to better understand the natural history of CKD and CVD in this high-risk population, we will identify unique risk factors for CKD and CVD progression in AIs. We will also compare event rates and risk factors for kidney and cardiovascular events in AIs with the other populations represented in CRIC.
慢性肾脏病(CKD)是一种在全球范围内不断增加的流行疾病,与不良健康结局相关,包括终末期肾病(ESKD)、心血管疾病(CVD)和死亡。美国印第安人(AIs)的 CKD 患病率高于大多数其他种族/民族群体,部分原因是 2 型糖尿病的患病率较高。其他尚未确定的遗传和环境因素也可能导致 AIs 中 CKD 的负担不成比例。
我们将建立 3 个临床中心,从美国西南部招募 AIs,以扩大慢性肾功能不全队列(CRIC)研究。我们将遵循当前的 CRIC 方案进行肾脏和心血管措施和结局的研究,包括对肾脏功能的动态监测以及使用移动健康技术进行 CVD 亚表型分析,并将 AIs 的结局与 CRIC 中其他种族/民族群体的结局进行比较。
AI-CRIC 将确定美国西南部 AIs 肾功能迅速丧失的各种风险因素的作用。此外,为了更好地了解该高危人群中 CKD 和 CVD 的自然史,我们将确定 AIs 中 CKD 和 CVD 进展的独特风险因素。我们还将比较 AI 与 CRIC 中其他人群的肾脏和心血管事件的发生率和风险因素。